FFR Technologies

This channel includes news and new technology innovations for fractional flow reserve (FFR) wires, catheters and systems used to measure blood flow across a coronary lesion to determine if a stent is needed or if the plaque stenosis can be treated medically. The section includes iFR, instantaneous wave-free ratio, systems used in the cath lab and noninvasive FFR technologies including computed tomography-FFR. This is also referred to as CT-FFR or FFR-CT.

Corindus CorPath robotic system

The Corindus CorPath robotic system allows interventional cardiologists to navigate coronary vessels without the need to be in the radiation field.

Feature | November 06, 2012 | By Dave Fornell
Hospitals constantly try to predict what the future holds when planning new facilities and equipment purchases that...
ST. Jude Medical PressureWire FFR Catherter
Feature | October 30, 2012
October 30, 2012 — Fractional flow reserve (FFR)-guided treatment was shown to be cost effective for guiding coronary...
News | September 17, 2012
September 17, 2012 — The Cardiovascular Research Foundation (CRF) announced the late-breaking trials and first report...
News | September 11, 2012
September 11, 2012 — Data presented at the 2012 European Society of Cardiology (ESC) Congress in Munich, Germany, from...
Feature | September 07, 2012
September 7, 2012 — St. Jude Medical Inc. announced results of the FAME II trial demonstrating that patients with...
FFR-CT imaging developed by HeartFlow offers coronary flow data noninvasively. Clinical data so far shows close correlation with invasive catheter-based FFR measurements. The technology helps pinpoint ischemic culprit lesions and determine the severity of coronary stenosis.

FFR-CT imaging developed by HeartFlow offers coronary flow data noninvasively. Clinical data so far shows close correlation with invasive catheter-based FFR measurements. The technology helps pinpoint ischemic culprit lesions and determine the severity of coronary stenosis.

Feature | CT Angiography (CTA) | July 30, 2012 | Dave Fornell
Trends and new technology for cardiac computed tomography angiography (CCTA) were highlighted during the 2012 Society...
News | May 24, 2012
May 24, 2012 — Volcano Corp. provided an overview of data from multiple ground-breaking clinical trials presented last...
News | May 21, 2012
May 21, 2012 -- St. Jude Medical Inc. announced that data from the FAME II trial demonstrated a significant difference...
News | April 23, 2012
April 23, 2012 - Abbott and St. Jude Medical announced ChoiceAlliance, a multi-year joint initiative that provides...
Videos | Intravascular Imaging | April 06, 2012
Several interventional cardiology experts share their views on how fractional flow reserve (FFR) and optical coherence...
Technology | March 29, 2012
March 29, 2012 — St. Jude Medical Inc. announced it has received U.S. Food and Drug Administration (FDA) clearance for...
Feature | March 27, 2012
March 24, 2012 — Coronary angiography is unable to accurately predict the severity of vessel narrowing, suggesting...
Feature | February 01, 2012 | Dave Fornell
Based on my observations and those of the doctors on the Diagnostic & Interventional Cardiology Editorial Advisory...
News | January 19, 2012
January 19, 2011 –– Interim analysis of the FAME II trial found a highly statistically significant reduction in the...
Blog | December 20, 2011
Each year that I attend Transcatheter Cardiovascular Therapeutics (TCT), I comb the event and its sessions looking...